Induced
hypothermia (lowering the body temperature to ≤35°C) attenuates
neuronal damage and provides neuroprotection mainly through lowering the
rate of metabolism. It thus finds applications in ameliorating the
secondary damage associated with traumatic brain injury, cardiac arrest,
and stroke. This article will focus on therapeutic hypothermia after
cardiac arrest.
Advantages of Hypothermia
For
each degree centigrade decrease in body temperature, cellular
metabolism is reduced by 5-7%, but the observed neuroprotective effect
of hypothermia is much greater than can be explained by reduced
metabolism alone [1].
During hypothermia the brain is exposed to
fewer excitatory neurotransmitters and has more time to clear free
radicals. It also reduces the average kinetic energy and hence the
velocities at which free radicals travel, effectively lowering the
likelihood that a free radical can damage vital cell parts before it
gets neutralized by the endogenous antioxidative system.
Altogether,
hypothermia induces a favorable shift in intracellular concentrations
of ions and metabolites such as inorganic phosphate, lactic acid, Ca2+ and H+, hence slowing brain acidosis [1].
Hypothermia Studies
Animal
studies of therapeutic hypothermia have shown profound neuroprotective
effects [1]. Despite being the most used model, the small rodent brain
is structurally, dimensionally, and metabolically different from the
proportionally bigger and complex human brain. Therefore, it probably
shows a greater response to neuroprotective efforts. Unlike with rodent
models human studies must take into consideration different
temperatures, duration of therapy, therapy onset/ending, cooling
methods, and factors such as age, gender, and pre-existing illness
[1,2]. Clinical studies of hypothermia after cardiac arrest have
therefore produced strongly inconsistent results.
The two largest
recent controlled studies on humans have shown significant improvements
in patients’ neurological outcome and survival. The European study on
“Mild therapeutic hypothermia to improve the neurologic outcome after
cardiac arrest” showed a reduction in mortality by 14% and a 16%
increase in patients with a good neurological outcome (able to live
independently ½ year after cardiac arrest) in the hypothermia group. The
2002 Australian study on “Treatment of Comatose Survivors of
Out-of-Hospital Cardiac Arrest with Induced Hypothermia” demonstrated a
26% increase in patients with a good neurological outcome [1,3].
Cooling Methods
Cooling
must be accompanied by the use of sedatives and neuromuscular blockers,
otherwise treatment will cause shivering and hence re-warming of the
body with a counterproductive increase in energy/oxygen consumption. A
good treatment protocol and adequate monitoring is required to
successfully apply hypothermia.
Many adequate cooling methods are
available and, with advancing medical technology, even more have become
available. One such new device is an intravascular heat exchanger [3],
which allows for rapid cooling and exact monitoring of blood flow and
temperature. Another new internal cooling method is the intravenous
infusion of iced isotonic fluid, such as saline solution [2,3]. Because
saline solution is readily available even in a pre-hospital setting and
safe to use regardless of age or gender, this is a suitable candidate
for the early initiation of hypothermia. It is nevertheless necessary to
maintain the cooled state with other methods later [2,3].
External
methods include the application of ice packs to areas with a high heat
exchange capability like the armpits, neck, groin or the head in the
form of a cooling helmet [3,4]. However, proper placing of these devices
requires a breach of privacy, especially when carried out in a
pre-hospital setting. In addition the rate of cooling is relatively
slow. Alternative methods include the use of cooling blankets or
wet-evaporative cooling [4].
Hypothermia should be initiated as
soon as safely possible but homeostatic imbalances induced by ischemia
and the physical insult of reperfusion will persist for days. Hence
there is a long time window (48-72h) to initiate and maintain
hypothermia. Any one cooling method alone has shown lower efficacy than
two or more methods combined. That and the rapid invention and inclusion
of new cooling methods is one reason why an optimal therapy has not
been developed and should therefore be researched and compared across
qualified hospitals around the world.
[1] Poldermann, Intensive Care Med, 2004
[2] Peberdy et al, Circulation, 2010
[3] Nolan et al, Circulation, 2003
[4] http://bit.ly/13SyEz4
By Rick Cornell Hellmann, Alumni Medical Neurosciences, AG Spinal Cord Injury
No comments:
Post a Comment